PREVALENCE OF CUTANEOUS ADVERSE DRUG REACTIONS ACCORDING TO IRAQI PHARMACOVIGILANCE CENTER; A RETROSPECTIVE STUDY FOR 11 YEARS (2010-2021)

Prevalence of Cutaneous Adverse Drug Reactions According to Iraqi Pharmacovigilance Center; A retrospective study for 11 years (2010-2021)

Background: Cutaneous Adverse Drug Reactions (CADRs) are among the leading causes of morbidity and mortality.Insufficient data exists on cutaneous adverse reactions, as many of these reactions are not reported due to their constantly changing patterns Diabetes Monitoring - Lancets and Lancing Devices and the interaction of multiple risk factors.Aim

read more